Smiths Group (SMGZY) Downgraded by Zacks Investment Research

Smiths Group (OTCMKTS:SMGZY) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research note issued on Wednesday.

According to Zacks, “Smiths Group plc is a technology company. The Company designs, manufactures and delivers products and services for the threat & contraband detection, medical devices, energy and communications market. Its operating segment consists John Crane sector provides mechanical seals, seal support systems, engineered bearings, power transmission couplings and specialist filtration systems, Smiths Medical sector provides infusion systems, vascular access, patient airway and temperature management equipment and specialty devices. Smiths Detection sector provides sensors that detect and identify explosives, narcotics, weapons, chemical agents, biohazards and contraband; Smiths Interconnect sector provides specialised electronic and radio frequency components and sub-systems that connect, protect and control critical systems; Flex-Tek division provides engineered components that heat and move fluids and gases, flexible hosing and rigid tubing. Smiths Group plc is headquartered in London, the United Kingdom. “

A number of other equities analysts also recently commented on the company. Numis Securities downgraded Smiths Group from an “add” rating to a “reduce” rating in a report on Friday, March 23rd. Barclays began coverage on Smiths Group in a report on Tuesday, February 13th. They set an “overweight” rating for the company.

Shares of Smiths Group stock opened at $23.13 on Wednesday. The company has a quick ratio of 1.83, a current ratio of 2.46 and a debt-to-equity ratio of 0.78. The company has a market cap of $9.00 billion, a P/E ratio of 18.80, a price-to-earnings-growth ratio of 2.35 and a beta of 1.18. Smiths Group has a 52 week low of $19.14 and a 52 week high of $23.87.

Smiths Group Company Profile

Smiths Group plc designs, manufactures, and sells various products and services for the threat and contraband detection, medical devices, energy, communications, and engineered components markets worldwide. It operates through John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek divisions.

Get a free copy of the Zacks research report on Smiths Group (SMGZY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit